KCT0006081
Recruiting
未知
A randomized clinical trial to evaluate the safety and effectiveness of the full-veneer crown fabricated with a 3D printed resin material for definitive prosthesis
Yonsei University Health System, Dental Hospital0 sites60 target enrollmentTBD
ConditionsCodes for special purposes
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Codes for special purposes
- Sponsor
- Yonsei University Health System, Dental Hospital
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients over 19 years of age
- •Patients who have signed consent for clinical research
- •Patients requiring single fixed posterior prosthetic treatment
- •Patients without non\-functional movements such as teething
- •Patients without jaw joint and other occlusal disorders
- •Patients whose opposing teeth are natural teeth
Exclusion Criteria
- •Patients unable to read the consent
- •Patients with uncontrolled systemic disease
- •Patients with active lesions or symptoms on the tooth being restored
- •patients with hypersensitivity to zirconia or resin materials
- •patients who Inappropriate participation at the discretion of the principal investigator as it can affect the outcome of other ethical or clinical studies
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A clinical trial to study the safety and practicability of mono polar urethral route removal of prostate without post-surgery urinary catheter traction in patients with enlarged prostateHealth Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary systemCTRI/2022/01/039199Abhineeth K P
Active, not recruiting
Not Applicable
Evaluation of the safety and effectiveness of esmolol and metoprolol for heart rate reduction during heart CT examinatioHeart rate control of patients referred to coronary computed tomography angiography (CCTA) due to suspected coronary artery disease are to investigated with esmolol and metoprolol. Acquiring diagnostic image quality with CCTA requires relative low and stable heart rate of the patients during examination. Thus, heart rate control with beta-blocker medication (esmolol, metoprolol) is recommended. However no current guideline is available regarding esmolol administration during CCTA.MedDRA version: 14.1Level: PTClassification code 10011078Term: Coronary artery diseaseSystem Organ Class: 10007541 - Cardiac disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2013-000048-24-HUHear Center of Semmelweis University
Completed
Not Applicable
A Prospective Randomized Clinical Trial to Validate Atrial Fibrillation Substrate Ablation for Non-Paroxysmal Atrial Fibrillatioatrial fibrillationJPRN-UMIN000051524Tsuchiura Kyodo General Hospital130
Not yet recruiting
Phase 2
se of Olaparib, a drug that inhibits an enzyme linked to inflammatory response and DNA repair, in sepsisRBR-8xdc8yzEscola Paulista de Medicina, Universidade Federal de São Paulo
Recruiting
Not Applicable
A comparison of radioactive iodine therapy versus anti-thyroid drugs as initial treatment for Graves diseaseCTRI/2016/03/006728Department of Internal Medicine90